FDA approves magnetic stimulation to treat OCD

Published August 17, 2018 3:45pm ET



A device that sends electric currents to the brain has been approved by the Food and Drug Administration for the treatment of obsessive compulsive disorder.

The device, known as the Brainsway Deep Transcranial Magnetic Stimulation System, was previously only approved to treat depression and headaches. The procedure uses magnetic fields to stimulate nerve cells in the brain.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.